1McGarry JD.Dysregulation of fatty acid merabolism inrhe etiology of type 2.diabetes,2001, 50 (Suppl2): 6-8.
2Laakso M, Lehto S, Penttila I, et al. Mortlity from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction,Neng J Med,1998, 339:229-234.
3Turner RC, Millns H, Neil HA, et al.Risk faetros for coronary artery disease in non-insulin dependent diabetes mellitus (UKPDS: 23) .BMJ, 1998, 316: 823-823.
4Howard BV, Robbins DC, Sievers ML, et al. LDL cholesterol as a strong predictor of coronary heart' disease in diabetic individuals with insulin resistance and low LDL: the Strong Heart Study: Arterioscler Thromb Vase Biol, 2000, 20:830-835.
5Pyorala K, Pederson TR, KjekshusJ, et al.For the Scandinavian Simvestatin Survival study: Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease: a subgroup analysis of the Scandinvavian Simvastation Survival Study (4S) .Diabetes Care 1997, 20:614-620.
6Grover SA, Coupal L, Zowall H, Dorais. Cost effectiveness of treating hyperlipidemia in the presence of diabetes : who should be treated? Circulation, 2000, 102 (7) :722-727.
